Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Viridian Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 72
- +17 vs. Q4 2021
- Shares held
- 24.9M
- +1.67M (+7.2%) vs. Q4 2021
- Total value
- $460.9M
- +$1.09M (+0.2%) vs. Q4 2021
- New holders
- 20
- 24 more added
- Sold out
- 3
- 16 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 1,852,919 | $34.3M | 5.55% | 00.0% | Unchanged |
| BVF Inc | 1,744,012 | $32.2M | 1.29% | −135,400−7.2% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,739,530 | $32.2M | 2.74% | +1,739,530 | New |
| Perceptive Advisors LLC | 1,423,053 | $26.3M | 0.55% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,314,000 | $24.3M | 9.75% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,300,000 | $24.0M | 1.66% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,256,051 | $23.2M | 6.14% | +47,000+3.9% | Added |
| Deep Track Capital, LP | 1,170,290 | $21.6M | 1.40% | −166,400−12.4% | Reduced |
| Avidity Partners Management LP | 1,040,000 | $19.2M | 0.43% | −238,261−18.6% | Reduced |
| Cormorant Asset Management, LP | 1,000,000 | $18.5M | 1.42% | +700,000+233.3% | Added |
| Millennium Management LLC | 975,618 | $18.0M | 0.02% | +513,228+111.0% | Added |
| Commodore Capital LP | 951,339 | $17.6M | 3.93% | +103,656+12.2% | Added |
| Fairmount Funds Management LLC | 944,092 | $17.5M | 4.13% | 00.0% | Unchanged |
| Citadel Advisors LLC | 941,218 | $17.4M | 0.02% | −2,122−0.2% | Reduced |
| Vanguard Group Inc | 940,577 | $17.4M | 0.00% | +14,901+1.6% | Added |
| D. E. Shaw & Co., Inc. | 783,095 | $14.5M | 0.02% | +18,482+2.4% | Added |
| Franklin Resources Inc | 600,023 | $11.1M | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 589,826 | $10.9M | 3.55% | +301,892+104.8% | Added |
| Ally Bridge Group (NY) LLC | 496,012 | $9.17M | 6.80% | −108,762−18.0% | Reduced |
| Ghost Tree Capital, LLC | 466,403 | $8.62M | 4.27% | −33,597−6.7% | Reduced |
| Acuta Capital Partners, LLC | 340,000 | $6.29M | 2.99% | +22,000+6.9% | Added |
| Point72 Asset Management, L.P. | 300,000 | $5.55M | 0.02% | −172,864−36.6% | Reduced |
| Woodline Partners LP | 221,257 | $4.09M | 0.07% | −36,413−14.1% | Reduced |
| Atlas Venture Advisors, Inc. | 209,505 | $3.87M | 0.83% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 199,238 | $3.68M | 0.00% | −2,440−1.2% | Reduced |
| Walleye Capital LLC | 162,281 | $3.00M | 0.09% | +52,106+47.3% | Added |
| Eversept Partners, LP | 155,743 | $2.88M | 0.27% | −38,846−20.0% | Reduced |
| BlackRock Inc. | 152,775 | $2.83M | 0.00% | −351−0.2% | Reduced |
| Silverarc Capital Management, LLC | 126,136 | $2.33M | 1.27% | +2,330+1.9% | Added |
| Pura Vida Investments, LLC | 105,460 | $1.95M | 0.24% | +600+0.6% | Added |
| ExodusPoint Capital Management, LP | 97,745 | $1.81M | 0.03% | +20,988+27.3% | Added |
| Susquehanna International Group, LLP | 97,527 | $1.80M | 0.00% | +97,527 | New |
| Atlas Venture Life Science Advisors, LLC | 90,072 | $1.67M | 0.21% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 90,000 | $1.66M | 0.26% | 00.0% | Unchanged |
| Endurant Capital Management LP | 83,217 | $1.54M | 0.46% | +15,767+23.4% | Added |
| Goldman Sachs Group Inc | 66,598 | $1.23M | 0.00% | +66,598 | New |
| State Street Corp | 66,000 | $1.22M | 0.00% | +31,959+93.9% | Added |
| Jane Street Group, LLC | 61,518 | $1.14M | 0.00% | +61,518 | New |
| Squarepoint Ops LLC | 61,390 | $1.14M | 0.01% | +61,390 | New |
| Polar Asset Management Partners Inc. | 59,700 | $1.10M | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 56,487 | $1.04M | 0.00% | −2,841−4.8% | Reduced |
| LMR Partners LLP | 52,774 | $976.0K | 0.01% | +11,374+27.5% | Added |
| Driehaus Capital Management LLC | 50,000 | $925.0K | 0.01% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 50,000 | $925.0K | 0.37% | +50,000 | New |
| HighVista Strategies LLC | 49,065 | $907.0K | 0.58% | +49,065 | New |
| Morgan Stanley | 34,929 | $646.0K | 0.00% | +21,234+155.0% | Added |
| Qube Research & Technologies Ltd | 33,187 | $614.0K | 0.01% | +16,187+95.2% | Added |
| Citigroup Inc | 28,140 | $520.0K | 0.00% | +13,256+89.1% | Added |
| Maven Securities LTD | 27,486 | $508.0K | 0.11% | +5,535+25.2% | Added |
| HRT Financial LP | 24,092 | $445.0K | 0.00% | +24,092 | New |
| Bank of Montreal | 23,000 | $414.0K | 0.00% | +23,000 | New |
| Ensign Peak Advisors, Inc | 21,405 | $396.0K | 0.00% | +21,405 | New |
| JPMorgan Chase & Co | 18,666 | $345.0K | 0.00% | +5,633+43.2% | Added |
| 683 Capital Management, LLC | 18,265 | $338.0K | 0.02% | −3,363−15.5% | Reduced |
| Bank of America Corp | 17,833 | $330.0K | 0.00% | +8,319+87.4% | Added |
| Marshall Wace, LLP | 17,563 | $326.0K | 0.00% | −70,842−80.1% | Reduced |
| Barclays PLC | 17,000 | $314.0K | 0.00% | +17,000 | New |
| Balyasny Asset Management LLC | 16,303 | $301.0K | 0.00% | +16,303 | New |
| Atom Investors LP | 16,106 | $298.0K | 0.14% | −2,778−14.7% | Reduced |
| Weiss Asset Management LP | 15,000 | $277.0K | 0.01% | +15,000 | New |
| Sciencast Management LP | 14,745 | $275.0K | 0.06% | +14,745 | New |
| PDT Partners, LLC | 14,390 | $266.0K | 0.02% | +1,775+14.1% | Added |
| Cannon Global Investment Management, LLC | 12,600 | $233.0K | 0.17% | +12,600 | New |
| Gyon Technologies Capital Management, LP | 12,187 | $225.0K | 0.16% | +12,187 | New |
| Royal Bank of Canada | 6,937 | $128.0K | 0.00% | +6,937 | New |
| Dorsey Wright & Associates | 2,511 | $46.0K | 0.01% | +2,511 | New |
| Tower Research Capital LLC (TRC) | 2,478 | $45.0K | 0.00% | +2,477+247,700.0% | Added |
| Cutler Group LP | 1,550 | $28.0K | 0.00% | +1,550 | New |
| Ovata Capital Management Ltd | 400 | $7.00K | 0.00% | +400 | New |
| Wells Fargo & Company | 311 | $5.00K | 0.00% | −175−36.0% | Reduced |
| UBS Group AG | 222 | $4.00K | 0.00% | +209+1,607.7% | Added |
| GPS Wealth Strategies Group, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,505,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −21,512−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −12,216−100.0% | Sold out |